Jan 28, 2026 3-5pm ET
Wednesday on The Robert Scott Bell Show:
Hour 1
Shared Decision-Making on Vaccines Is Not the Enemy The article argues that public health officials and medical professionals are making a strategic and ethical mistake by treating shared clinical decision-making (SCDM) on vaccines as a threat rather than embracing it as a core expression of informed consent and patient autonomy. The author, a veteran risk communication expert, explains that while the scientific evidence supporting the safety and effectiveness of the six vaccines moved to SCDM under the revised pediatric vaccine schedule remains strong and unchanged, the backlash against the policy has wrongly framed SCDM as signaling weaker evidence or optionality. He contends that informed consent in vaccination has too often become a perfunctory ritual rather than a genuine discussion, driven by a presumptive approach that prioritizes compliance and uptake over agency and open dialogue. While acknowledging that presumptive strategies can increase short-term vaccination rates, he warns that sidelining patient and parental choice erodes legitimacy, trust, and long-term confidence in public health institutions. The author criticizes vaccine advocates for amplifying the perception that vaccines are now optional by repeatedly framing SCDM that way in public discourse, inadvertently reinforcing the very narrative they fear. He also argues that by resisting patient choice, public health cedes moral ground to critics by appearing authoritarian rather than confident in the strength of vaccine science. The piece maintains that true confidence would involve clearly affirming the evidence, explicitly recognizing the right of parents to decide, and supporting candid clinician guidance within a shared decision-making framework for all vaccines. The author concludes that while respecting choice may carry health tradeoffs, especially in the short term, coercive or dismissive approaches ultimately provoke resistance, whereas respectful engagement and persuasion are more likely to sustain trust and long-term vaccine acceptance in a free society.
California Becomes First State to Join WHO Disease Network After U.S. Exit California Governor Gavin Newsom announced that his state will join a World Health Organization (WHO) disease surveillance network even after the United States formally withdrew from WHO membership, making California the first U.S. state to participate in the international public health collaboration. Newsom framed the move as a pragmatic decision to ensure California retains access to global disease tracking, data sharing, and early warning systems for outbreaks and health threats, asserting that public health protection for Californians requires engagement with international partners despite federal policy shifts that pulled the United States out of WHO in 2026 following criticism from the current presidential administration. The decision reflects a broader tension between state and federal approaches to public health, with California often pursuing independent strategies on issues ranging from climate to immigration to health care, and showcases Newsom’s willingness to position the state as a leader in international cooperation on health security even amid political disagreements with national leadership. Critics of the move argue it could undermine national sovereignty and send mixed signals about American health policy priorities, especially after the U.S. exit was justified by concerns about WHO’s governance and responses to past global health emergencies. Supporters, including public health experts and state officials, counter that the collaboration will enhance California’s capacity to monitor infectious diseases, respond quickly to emerging threats, and align state surveillance with global standards, potentially benefiting residents through faster detection and response mechanisms that transcend borders.
Common Plastic Chemical BPA Found To Feminize Males and Masculinize Females Recent animal research shows that very low exposure to the plastic-associated chemical bisphenol A (BPA) before birth can produce long-lasting, sex-specific biological changes, with male rats exposed in utero exhibiting gene expression patterns more typical of females and female rats showing patterns more typical of males when they reach adulthood, influencing metabolic, immune, and disease-related pathways later in life. Scientists in the study administered BPA to pregnant rats at exposure levels comparable to typical human daily intake as well as higher doses that were previously considered safe, and then examined the adult offspring’s gene activity and blood biomarkers, finding that BPA exposure altered metabolic profiles in ways linked to increased risk of cancer-like pathways in females and metabolic syndrome risks such as diabetes and heart disease in males, and also affected immune cell behavior in opposite directions between the sexes. BPA, a synthetic compound with estrogen-like properties still present in some food packaging and other plastics despite bans in certain products, disrupted bone marrow gene expression and metabolic markers in exposed animals, supporting broader concerns that endocrine-disrupting chemicals can have persistent effects beyond traditional toxicological endpoints; these findings align with calls by regulatory bodies like the European Food Safety Authority to drastically lower tolerable intake levels based on potential health risks, and reinforce earlier research associating BPA with hormone-related conditions such as polycystic ovary syndrome and altered fertility, suggesting that even low-dose developmental exposure may have lasting impacts on sex-specific biology.
Scientists Just Calculated How Many Microplastics Are in Our Atmosphere Scientists have generated the first quantitative estimate of microplastic particles circulating in the Earth’s atmosphere, finding that land sources alone emit an astonishing approximately 600 quadrillion microplastic particles each year, far exceeding contributions from the oceans, which total about 26 quadrillion particles annually, and demonstrating that airborne microplastic pollution is far more pervasive than previously known. This estimate, derived from a study published in Nature, suggests that the atmosphere over land contains a median concentration of about 0.08 microplastic particles per cubic meter, with lower concentrations over the ocean at roughly 0.003 particles per cubic meter, illustrating the widespread dispersal of microscopic plastic fragments that originate from urban, agricultural, and industrial activities and become entrained in air currents that can carry them over great distances, including into remote regions. Researchers emphasize that microplastics are now ubiquitous across Earth’s surface — from deserts to polar regions — and that understanding the scale of atmospheric microplastic emissions is an important step in assessing their potential environmental and human health impacts, although many uncertainties remain regarding how these particles interact with climate systems, cloud formation, and biological processes. The findings highlight the need for expanded monitoring and deeper investigation into the pathways and consequences of airborne plastic pollution as part of broader efforts to map the global plastic cycle and its implications.
Welcome back to another “Homeopathic Hits” episode on The Robert Scott Bell Show!
On The Robert Scott Bell Show today, we highlight Vespa crabro — a remedy Boericke associates with acute inflammatory reactions marked by violent stinging pains, rapid swelling, and erysipelatous inflammation
Its picture reflects the effects of hornet poison, with intense local reaction, redness, heat, and edema, often developing suddenly.
Download the Information Sheet
Hour 2
WEF Calls for Cultural Revolution to Promote Lab-Grown Meat An article reports that participants at the World Economic Forum (WEF) annual meeting in Davos, Switzerland, urged a “cultural revolution” to increase consumer acceptance of lab-grown or cultivated meat despite what they described as widespread public resistance to these products. According to the story, WEF panelists framed the shift to lab-grown meat as part of efforts to reduce consumption of conventional animal products, which some climate or health advocates argue contributes heavily to ecological footprints and noncommunicable diseases. Opponents quoted in the piece expressed concerns that lab-grown foods centralize food production into proprietary systems controlled by corporate and global elites at the expense of decentralized, farmer-based networks and food sovereignty. Critics also raised questions about novel biological risks from lab-grown meat technologies—such as the use of immortalized cell lines and unknown long-term effects—while pointing to low market demand for alternative meats and regulatory or legal pushback in several U.S. states that have banned or restricted lab-grown meat sales. The article positions the WEF’s advocacy for cultivated meat as emblematic of broader debates over industrialized food systems, consumer choice, environmental narratives, and authority over food innovation and regulation
Florida Bill Expands Vaccine Exemptions but Keeps Mandates in Law A proposed Florida legislative bill would leave the state’s existing statutory vaccine requirements in place — including mandated shots for diseases such as polio and measles — but expand parents’ ability to opt out by creating a new “conscience-based” exemption that allows parents to decline vaccinations for their children beyond the current religious exemption under state law, a shift anticipated to move through committee this session. The bill, sponsored by Senator Clay Yarborough, would also require health care providers to offer parents information on the risks, benefits, safety and efficacy of vaccines approved by the state medical boards before administering them to children, and allow parents some flexibility in how multiple vaccines are scheduled. Advocates of the legislation argue that it enhances parental control and medical freedom without fundamentally undermining existing requirements, while critics — including some families, doctors and at least one state senator — warn it could jeopardize public health and put vulnerable populations at risk by increasing exemptions and reducing overall immunization coverage. The Florida Department of Health is also separately pursuing administrative changes that could eliminate four vaccine requirements without legislative approval, reflecting broader debate within the state over how vaccine policy should balance individual choice and community protection.
HHS Bars Research Using Human Fetal Tissue from Elective Abortions The U.S. Department of Health and Human Services (HHS) announced that it is ending the use of human fetal tissue obtained from elective abortions in agency-funded research, with the policy change applying across the National Institutes of Health (NIH) intramural programs and all NIH-supported extramural grants, contracts, and research agreements, in a shift aimed at aligning federal research funding with ethical considerations and modern scientific alternatives. Health and Human Services Secretary Robert F. Kennedy Jr. said the policy reflects a priority on advancing “gold-standard science” while upholding the sanctity of human life, and NIH Director Jay Bhattacharya framed the decision as part of modernizing biomedical research by directing resources toward emerging technologies such as organoids, tissue chips, and computational biology that the agency says can reduce reliance on fetal tissue models. The policy reverses guidance from earlier in the decade and reinstates a more comprehensive restriction on research involving human fetal tissue from elective abortion that had been rolled back under a previous administration, and it follows a broader suite of actions by HHS reinforcing conscience protections and federal commitments against elective abortion funding. While the issue is politically and ethically contentious, advocates for the ban, including anti-abortion groups, welcomed the change as consistent with pro-life values, and HHS officials emphasize the department’s commitment to ethically sound science; critics including many biomedical researchers argue that fetal tissue has been crucial for decades in studying human development and disease and that adequate alternatives do not yet exist for all research purposes and could slow progress in understanding and treating serious conditions.
Moderna Curbing Investments in Vaccine Trials Due to U.S. Backlash, CEO Tells Bloomberg TV Moderna’s chief executive officer, Stéphane Bancel, said the company will scale back plans to invest in new late-stage vaccine clinical trials because growing opposition to immunization among U.S. officials and the resulting regulatory environment have made the U.S. market less viable and return on investment harder to achieve, remarks he made in an interview at the World Economic Forum in Davos, Switzerland. Bancel explained that without strong support and clearer regulatory pathways in the United States, potential market size for new vaccines shrinks, deterring commitments to costly phase-3 development, and noted that investors and the company must consider where demand and policy support remain robust. The comments reflect broader concern in the pharmaceutical and biotech communities about changes in U.S. vaccine recommendations and policies, which have included reduced federal guidance on COVID-19 shots for certain populations and other shifts that industry leaders say have dampened uptake and introduced uncertainty for future commercial prospects, influencing strategic decisions on research funding and clinical testing. Reuters reporting also noted that Moderna’s stock reacted positively to the news, rising more than 10 percent in early trading following Bancel’s remarks.
Candy Under Microscope: Florida Testing Reveals Arsenic in Sweet Treats Florida health officials announced results from testing conducted under the state’s Healthy Florida First initiative that found elevated levels of arsenic in the majority of popular candy products tested, raising concerns about children’s exposure to this toxic element and prompting calls for greater transparency and accountability in the food supply. The Florida Department of Health tested 46 candy products from ten companies for heavy metals and detected arsenic in 28 of them, including sweets such as SweeTarts, Jolly Ranchers, Trolli Sour Brite Crawlers, Twizzlers, Sour Patch Kids, and various Nerds and gummy candies, while other candies like Hershey Milk Chocolate Bar, Reese’s Peanut Butter Cups, Whoppers, M&M’s, Twix and Milky Way did not exceed safety levels. State Surgeon General Joseph Ladapo noted that long-term exposure to arsenic, particularly in childhood when dietary intake relative to body weight is higher and detoxification mechanisms are less developed, has been associated with developmental effects, immune system impacts, and increased cancer risk, and emphasized the need for parents to have information to make informed choices about products marketed to children. First Lady Casey DeSantis, speaking at a news conference, called for transparency and accountability in food production so that parents can trust that foods in the marketplace do not contain harmful contaminants and highlighted that such testing builds on earlier work analyzing infant formula for heavy metals. The candy testing results are part of a broader push by state officials to evaluate and communicate chemical and heavy metal exposure risks in foods consumed by children and to encourage industry standards that limit such contaminants.
Remember Friends, The Power to Heal is Yours!
